To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Speech in Lords Chamber - Thu 24 Jun 2021
Social Care and the Role of Carers

"My Lords, I too congratulate the noble Baroness, Lady Jolly, and echo the thanks for the wonderful work done by carers. Our care system is broken: every part of it is in need of radical change, from the arbitrary distinction between what counts as social care and what qualifies you …..."
Baroness Altmann - View Speech

View all Baroness Altmann (Non-affiliated - Life peer) contributions to the debate on: Social Care and the Role of Carers
Speech in Lords Chamber - Wed 23 Jun 2021
Folic Acid

"My Lords, from my noble friend’s responses, the House will be clear that this decision is under way. Could my noble friend give some idea of whether we might expect an announcement before the Summer Recess? We know that hundreds of children being born with spina bifida and anencephaly, which …..."
Baroness Altmann - View Speech

View all Baroness Altmann (Non-affiliated - Life peer) contributions to the debate on: Folic Acid
Written Question
Coronavirus: Vaccination
Tuesday 22nd June 2021

Asked by: Baroness Altmann (Non-affiliated - Life peer)

Question to the Department of Health and Social Care:

To ask Her Majesty's Government what plans they have to protect individuals who are immuno-compromised and therefore cannot be vaccinated against COVID-19; and whether they plan to offer those individuals plasma from people who have either (1) recovered from COVID-19, or (2) been fully vaccinated.

Answered by Lord Bethell

All immunocompromised people have been offered a COVID-19 vaccination. We continue to monitor vaccine efficacy to identify groups, such as the immunocompromised, who may require additional support. Immunocompromised individuals are a priority cohort for research into therapeutic and prophylaxis treatments such as monoclonal antibody therapies, novel antivirals and repurposed compounds.

It is not yet possible to determine the exact cohort of patients who may benefit from these treatments, as this will depend on results released by ongoing trials as they conclude, licensing approval from the Medicines and Healthcare products Regulatory Agency and deployment planning. We are taking steps to ensure supply of treatments in the event that they are found to be effective. We are developing options for further clinical trials where necessary.

Convalescent plasma from people who have recovered from COVID-19 was found to not provide a clinical benefit in hospitalised patients in the RECOVERY clinical trial. However, we keep the evidence under review for all neutralising antibody therapies including convalescent plasma. The NHS Blood and Transplant study C-VELVET will provide information on the levels of antibodies produced by patients post vaccination and could support further research and development of antibody therapies.

Written Question
Coronavirus: Vaccination
Monday 21st June 2021

Asked by: Baroness Altmann (Non-affiliated - Life peer)

Question to the Department of Health and Social Care:

To ask Her Majesty's Government how many individuals are medically unable to be vaccinated against COVID-19, either because they are (1) immuno-compromised, (2) undergoing cancer treatment, or (3) undergoing any other treatment rendering them unsuitable for vaccination.

Answered by Lord Bethell

Public Health England does not hold this data.

Speech in Lords Chamber - Thu 17 Jun 2021
Covid-19: Care Homes

"My Lords, I apologise to my noble friend for adding to the burden that he bears in answering this question. I know he cares deeply about this situation. However, it is important for lessons to be learned, so that we have no similar experience in future. The letter sent by …..."
Baroness Altmann - View Speech

View all Baroness Altmann (Non-affiliated - Life peer) contributions to the debate on: Covid-19: Care Homes
Speech in Lords Chamber - Tue 15 Jun 2021
Covid-19 Update

"My Lords, I commend my noble friend for all his work helping fight this dreadful pandemic; I know his dedication is second to none. I hope he will forgive me for asking: what is the endgame? He has said today that we must prevent people getting sick, but that seems …..."
Baroness Altmann - View Speech

View all Baroness Altmann (Non-affiliated - Life peer) contributions to the debate on: Covid-19 Update
Speech in Lords Chamber - Thu 10 Jun 2021
Carers: Support

"My Lords, will my noble friend join me in commending the work of unpaid carers in this country who have done so much to help through the pandemic? Will he request that Her Majesty’s Treasury and the Department for Work and Pensions consider increasing the carer’s allowance, which pays anyone …..."
Baroness Altmann - View Speech

View all Baroness Altmann (Non-affiliated - Life peer) contributions to the debate on: Carers: Support
Speech in Lords Chamber - Tue 25 May 2021
Heathrow Airport: Border Control Passenger Safety

"My Lords, Heathrow deserves credit for a number of the measures that it has been taking: dedicated channels for red-list arrivals, trialling a separate terminal for arrivals, and escorting people to separate areas. Would my noble friend agree that, if red-list arrivals are required to wait longer than others, there …..."
Baroness Altmann - View Speech

View all Baroness Altmann (Non-affiliated - Life peer) contributions to the debate on: Heathrow Airport: Border Control Passenger Safety
Speech in Lords Chamber - Thu 20 May 2021
Covid-19 Internal Review

"My Lords, I echo the congratulations to my noble friend on his dedication to his role, and I welcome the noble Baroness opposite to her position. I join other colleagues in congratulating the Government on their successful rollout of the vaccine, which, from what we can see so far, deals …..."
Baroness Altmann - View Speech

View all Baroness Altmann (Non-affiliated - Life peer) contributions to the debate on: Covid-19 Internal Review
Speech in Lords Chamber - Wed 28 Apr 2021
Care Home Occupancy Rate

"Will my noble friend join me in commending the excellent work of care staff during the appalling problems that have arisen over the past year during the pandemic? Will the Government urgently investigate the financial stability and debt levels of care home operators, which, too frequently, seem to have no …..."
Baroness Altmann - View Speech

View all Baroness Altmann (Non-affiliated - Life peer) contributions to the debate on: Care Home Occupancy Rate